Cargando…

Development and Validation of Nomograms for Predicting the Prognosis of Triple-Negative Breast Cancer Patients Based on 379 Chinese Patients

PURPOSE: We aimed to construct universally applicable nomograms incorporating prognostic factors to predict the prognosis of patients with triple-negative breast cancer (TNBC). PATIENTS AND METHODS: Clinicopathological data of 379 patients with TNBC from March 2008 to June 2014 were retrospectively...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Hao, Wang, Xiao-Hui, Gu, Jun-Wei, Guo, Gui-Long
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6941602/ https://www.ncbi.nlm.nih.gov/pubmed/31920392 http://dx.doi.org/10.2147/CMAR.S234926

Ejemplares similares

Development and validation of nomograms predicting survival in Chinese patients with triple negative breast cancer
por: Yang, Yaping, et al.
Publicado: (2019)

Nomogram for predicting overall survival in Chinese triple-negative breast cancer patients after surgery
por: Lin, Wei-Xun, et al.
Publicado: (2022)

Development and validation of a prognostic nomogram for patients with triple-negative breast cancer with histology of infiltrating duct carcinoma
por: Jing, Na, et al.
Publicado: (2020)

Development and validation of nomograms for predicting survival in patients with de novo metastatic triple-negative breast cancer
por: Chen, Mao-Shan, et al.
Publicado: (2022)

Construction and Validation of Nomograms Predicting Survival in Triple-Negative Breast Cancer Patients of Childbearing Age
por: Cui, Xiang, et al.
Publicado: (2021)

Development and validation of nomograms for predicting overall and breast cancer-specific survival among patients with triple-negative breast cancer
por: Guo, Lin-Wei, et al.
Publicado: (2018)

A nomogram prediction for the survival of patients with triple negative breast cancer
por: Lin, Yuxiang, et al.
Publicado: (2018)

hnRNPK S379 phosphorylation participates in migration regulation of triple negative MDA-MB-231 cells
por: Tsai, Hsin-Yu, et al.
Publicado: (2019)

Nomogram for Predicting Lymph Node Involvement in Triple-Negative Breast Cancer
por: Cui, Xiang, et al.
Publicado: (2020)

Establishment and Validation of Prognostic Nomograms Based on Serum Copper Level for Patients With Early-Stage Triple-Negative Breast Cancer
por: Duan, Fangfang, et al.
Publicado: (2021)

A Combined Nomogram Model to Predict Disease-free Survival in Triple-Negative Breast Cancer Patients With Neoadjuvant Chemotherapy
por: Xia, Bingqing, et al.
Publicado: (2021)

Diagnostic and Prognostic Nomograms for Lung Metastasis in Triple-Negative Breast Cancer
por: Wang, Jianguo, et al.
Publicado: (2022)

Stratification of Prognosis of Triple-Negative Breast Cancer Patients Using Combinatorial Biomarkers
por: Yue, Yong, et al.
Publicado: (2016)

T-cadherin is associated with prognosis in triple-negative breast cancer
por: Kong, De-Di, et al.
Publicado: (2017)

A novel conditional survival nomogram for monitoring real-time prognosis of non-metastatic triple-negative breast cancer
por: Meng, Xiangdi, et al.
Publicado: (2023)

Establishment and Validation of Novel Clinical Prognosis Nomograms for Luminal A Breast Cancer Patients with Bone Metastasis
por: Tu, QiHao, et al.
Publicado: (2020)

No association between triple-negative breast cancer and prognosis of patients receiving breast-conserving treatment
por: Mu, Lan, et al.
Publicado: (2017)

The role of BRCA status on prognosis in patients with triple-negative breast cancer
por: Xie, Yuxin, et al.
Publicado: (2017)

Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer
por: Qiu, Jingdan, et al.
Publicado: (2016)

Development and validation of an inflammatory response-related signature in triple negative breast cancer for predicting prognosis and immunotherapy
por: Guo, Yangyang, et al.
Publicado: (2023)

Nomogram Personalizes and Visualizes the Overall Survival of Patients with Triple-Negative Breast Cancer Based on the Immune Genome
por: Wang, Peipei, et al.
Publicado: (2020)

Nomogram for predicting overall survival in patients with triple-negative apocrine breast cancer: Surveillance, epidemiology, and end results-based analysis
por: Xu, Yinggang, et al.
Publicado: (2022)

Development and validation of a nomogram for predicting the prognosis in cancer patients with sepsis
por: Yang, Yong, et al.
Publicado: (2022)

BRCAness and Prognosis in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
por: Tanino, Hirokazu, et al.
Publicado: (2016)

Clinical features and prognosis of triple-negative breast cancer
por: Sanz, M Izquierdo, et al.
Publicado: (2009)

Development and validation of nomograms integrating immune‐related genomic signatures with clinicopathologic features to improve prognosis and predictive value of triple‐negative breast cancer: A gene expression‐based retrospective study
por: Wang, Kang, et al.
Publicado: (2019)

A Nomogram Based on Radiomics with Mammography Texture Analysis for the Prognostic Prediction in Patients with Triple-Negative Breast Cancer
por: Jiang, Xian, et al.
Publicado: (2020)

SAT-379 Giant Parathyroid Adenoma
por: Saberi, Sima, et al.
Publicado: (2020)

Impact of Triple-Negative Breast Cancer Phenotype on Prognosis in Patients with Stage I Breast Cancer
por: Kim, Jeong Eun, et al.
Publicado: (2012)

Down-regulated FST expression is involved in the poor prognosis of triple-negative breast cancer
por: Liu, Sainan, et al.
Publicado: (2021)

Development and validation of a nomogram to predict the prognosis of patients with gastric cardia cancer
por: Shi, Xiuquan, et al.
Publicado: (2020)

Expression of RUNX1 Correlates with Poor Patient Prognosis in Triple Negative Breast Cancer
por: Ferrari, Nicola, et al.
Publicado: (2014)

Accumulation of p62 is associated with poor prognosis in patients with triple-negative breast cancer
por: Luo, Rong-Zhen, et al.
Publicado: (2013)

Ki67 as a predictor of poor prognosis in patients with triple-negative breast cancer
por: LI, HAITAO, et al.
Publicado: (2015)

Incidence, pattern and prognosis of brain metastases in patients with metastatic triple negative breast cancer
por: Jin, Jia, et al.
Publicado: (2018)

CCNE1 amplification is associated with poor prognosis in patients with triple negative breast cancer
por: Zhao, Zi-Ming, et al.
Publicado: (2019)

Low KIBRA Expression Is Associated with Poor Prognosis in Patients with Triple-Negative Breast Cancer
por: Kim, So-Woon, et al.
Publicado: (2021)

Multi‑institutional development and validation of a nomogram to predict prognosis of early-onset gastric cancer patients
por: Liu, Hongda, et al.
Publicado: (2022)

Triple-negative breast cancer: current treatment strategies and factors of negative prognosis
por: Baranova, Anna, et al.
Publicado: (2022)

Update on triple-negative breast cancer: prognosis and management strategies
por: Brouckaert, Olivier, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ikldnol6vp8ilggsurcrucglth